Biochemical Markers of Bone Fragility in Patients With Diabetes.

Christian Meier Richard EastellDominique D PierrozNancy E LaneNasser Al-DaghriAtsushi SuzukiNicola NapoliAmbrish MithalMarlene ChakhtouraGhada El-Hajj Fuleihan Serge Livio Ferrari

Published in: The Journal of clinical endocrinology and metabolism (2023)

Several biochemical markers and hormonal levels related to bone and/or glucose metabolism have been associated with skeletal parameters in diabetes. Currently, only HbA1c levels seem to provide a reliable estimate of fracture risk, while BTMs could be used to monitor the effects of antiosteoporosis therapy.

Keyphrases

bone mineral density
type diabetes
cardiovascular disease
soft tissue
bone loss
bone regeneration
postmenopausal women
stem cells
glycemic control
body composition
insulin resistance
metabolic syndrome
polycystic ovary syndrome
replacement therapy